New Prostate Cancer Study Results from Thomas Jefferson University Described (The Nogo Receptor Ngr2, a Novel Alpha V Beta 3 Integrin Effector, Induces Neuroendocrine Differentiation In Prostate Cancer)

Press/Media

PeriodDec 8 2022

Media coverage

1

Media coverage

  • TitleNew Prostate Cancer Study Results from Thomas Jefferson University Described (The Nogo Receptor Ngr2, a Novel Alpha V Beta 3 Integrin Effector, Induces Neuroendocrine Differentiation In Prostate Cancer)
    Media name/outletCancer Daily
    Country/TerritoryUnited States
    Date12/8/22
    PersonsPeter A. McCue
View all 1
View less

Related content